BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21054547)

  • 1. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
    Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
    J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polaprezinc on taste disorders in zinc-deficient rats.
    Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
    Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.
    Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M
    Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of polaprezinc research].
    Takei M
    Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
    Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
    Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
    Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
    Sakae K; Yanagisawa H
    Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
    Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
    Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
    Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
    Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
    Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
    J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study.
    Sakagami M; Ikeda M; Tomita H; Ikui A; Aiba T; Takeda N; Inokuchi A; Kurono Y; Nakashima M; Shibasaki Y; Yotsuya O
    Acta Otolaryngol; 2009 Oct; 129(10):1115-20. PubMed ID: 19037756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
    Nishijima S; Yanase T; Hata Y; Tamura R; Tsuneki I; Tamura M; Kurabayashi T
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):689-92. PubMed ID: 21499007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
    Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
    Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
    Sakae K; Suka M; Yanagisawa H
    J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
    Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zinc deficiency on the vallate papillae and taste buds in rats.
    Chou HC; Chien CL; Huang HL; Lu KS
    J Formos Med Assoc; 2001 May; 100(5):326-35. PubMed ID: 11432312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral zinc therapy for zinc deficiency-related telogen effluvium.
    Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
    Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
    Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
    Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc-L-Carnosine Complex (Polaprezinc) for the Treatment of Binge Eating: Three Case Reports.
    Sakae K; Yanagisawa H
    J Clin Psychopharmacol; 2017 Dec; 37(6):734-736. PubMed ID: 28926352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.